Simplex Trading’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.55K | Buy |
+590
| New | +$5.29K | ﹤0.01% | 7707 |
|
|
2025
Q4 | – | Sell |
-1,500
| Closed | -$13K | – | 9245 |
|
|
2025
Q3 | $13K | Buy |
+1,500
| New | +$13.2K | ﹤0.01% | 7701 |
|
|
2025
Q2 | – | Sell |
-960
| Closed | -$10K | – | 9154 |
|
|
2025
Q1 | $10K | Sell |
960
-2,040
| -68% | -$22K | ﹤0.01% | 7091 |
|
|
2024
Q4 | $30K | Sell |
3,000
-1,640
| -35% | -$20.7K | ﹤0.01% | 6355 |
|
|
2024
Q3 | $76K | Buy |
4,640
+630
| +16% | +$8.97K | ﹤0.01% | 5490 |
|
|
2024
Q2 | $44K | Sell |
4,010
-780
| -16% | -$9.69K | ﹤0.01% | 6211 |
|
|
2024
Q1 | $63K | Buy |
4,790
+2,340
| +96% | +$30.4K | ﹤0.01% | 6053 |
|
|
2023
Q4 | $36K | Buy |
2,450
+2,190
| +842% | +$26.8K | ﹤0.01% | 6393 |
|
|
2023
Q3 | $3K | Sell |
260
-6,530
| -96% | -$126K | ﹤0.01% | 7901 |
|
|
2023
Q2 | $170K | Sell |
6,790
-2,730
| -29% | -$45.8K | ﹤0.01% | 4483 |
|
|
2023
Q1 | $141K | Buy |
9,520
+6,360
| +201% | +$118K | ﹤0.01% | 4750 |
|
|
2022
Q4 | $44K | Buy |
3,160
+3,080
| +3,850% | +$84K | ﹤0.01% | 6034 |
|
|
2022
Q3 | $2K | Sell |
80
-5,340
| -99% | -$223K | ﹤0.01% | 9289 |
|
|
2022
Q2 | $188K | Buy |
5,420
+5,400
| +27,000% | +$346K | ﹤0.01% | 4692 |
|
|
2022
Q1 | $2K | Sell |
20
-690
| -97% | -$79.9K | ﹤0.01% | 9858 |
|
|
2021
Q4 | $67K | Sell |
710
-490
| -41% | -$44.1K | ﹤0.01% | 6828 |
|
|
2021
Q3 | $155K | Hold |
1,200
| – | – | ﹤0.01% | 5993 |
|
|
2021
Q2 | $147K | Buy |
1,200
+1,194
| +19,900% | +$165K | ﹤0.01% | 6165 |
|
|
2021
Q1 | $87K | Buy |
6
+4
| +200% | +$679 | ﹤0.01% | 5934 |
|
|
2020
Q4 | $27K | Hold |
2
| – | – | ﹤0.01% | 6748 |
|
|
2020
Q3 | $42K | Buy |
+2
| New | +$328 | ﹤0.01% | 5771 |
|
|
2019
Q3 | – | Hold |
0
| – | -$2K | – | 7537 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6754 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$55K | – | 7372 |
|
|
2018
Q3 | $55K | Buy |
5
+2
| +67% | +$5.22K | ﹤0.01% | 5069 |
|
|
2018
Q2 | $807K | Buy |
+3
| New | +$6.93K | ﹤0.01% | 1981 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3870 |
|
|
2016
Q1 | – | Hold |
0
| – | -$3K | – | 5885 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4235 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1748 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2303 |
|
Other funds holding IMUX
APM
BI
VCM
SCM
LCM
NCM
6CM
Simplex Trading's IMUX Position: Q4 2025 in Review
Simplex Trading sold out of Immunic (IMUX) in Q4 2025, closing a stake of 438 shares — an estimated $3.21K sold.
Simplex Trading first reported a position in IMUX in Q4 2015 and held it in 21 quarters. The position peaked at $124K in Q1 2025. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2025.
- Simplex Trading reported no remaining Immunic position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 438 Immunic shares in Q4 2025, an estimated $3.21K.
- Simplex Trading first reported a position in Immunic in Q4 2015 and held it in 21 quarters.
- Simplex Trading's Immunic position peaked at $124K in Q1 2025.
- 58 funds tracked by Wall St. Rank held Immunic as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.